Page last updated: 2024-08-16

temozolomide and u 0126

temozolomide has been researched along with u 0126 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Ali-Osman, F; Augustine, CK; Beasley, GM; Burchette, J; Jung, SH; McMahon, N; Padussis, J; Pruitt, SK; Selim, MA; Toshimitsu, H; Tyler, DS; Yoo, JS; Yoshimoto, Y; Zipfel, PA	1
Banerjee, R; Belinsky, G; Huang, Y; Jean-Claude, BJ; McNamee, JP; Qiu, Q	1
Amaral, CL; Arjmand, N; Ashouri-Sanjani, M; Azimi, P; Brahmbhatt, P; Braverman, V; Bu, X; Chao, M; Clement, C; Contieri, LS; Costa, SO; Dai, L; Dong, W; Dou, W; Drineas, P; Edmonds, CR; Elnahas, T; Enterline, L; Feng, L; Fields, KG; Fragomen, A; Fusco, NM; Galal, S; Gao, J; Guo, K; Hamilton, A; Han, L; Harris, SN; He, X; Hinkley, J; Hu, Y; Huang, Q; Igboechi, O; Ignacio-Souza, LM; James, EW; Khabyeh-Hasbani, N; Lamplot, JD; Lawton, CD; Liguori, GA; Liu, W; Liu, Y; Lotfy, R; Lu, H; Madhusudhan, T; Martins, ICA; Meaney, CJ; Mehta, R; Meng, X; Milanski, M; Mohammadi-Moghadam, S; Musco, C; Ortolan, SC; Pearle, AD; Premkumar, A; Principe, P; Qu, X; Rasheed, MA; Rozbruch, SR; Salama, E; Salama, S; Salem, SM; Schultz, K; Sharaf, M; Shen, L; Shin, J; Souza, ACP; Sun, W; Thurnherr, E; Torsoni, AS; Torsoni, MA; Upadhyay, J; Wang, H; Wang, L; Wang, M; Wang, T; Wei, X; Woodruff, DP; Wu, J; Xie, Y; Yang, X; Zeng, H; Zhang, J; Zhang, W; Zhong, X; Zhou, S	1

Reviews

1 review(s) available for temozolomide and u 0126

Article	Year
Middle East Fertility Society journal, 2021, Volume: 26, Issue:1 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Basigin; beta-Transducin Repeat-Containing Proteins; Brain Neoplasms; Butadienes; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diabetic Cardiomyopathies; Diet, High-Fat; Dietary Supplements; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Endoribonucleases; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; Humans; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; NF-E2-Related Factor 2; Nitriles; Phosphorylation; Rats; Signal Transduction; Sumoylation; Temozolomide; Unfolded Protein Response; X-Box Binding Protein 1; Xenograft Model Antitumor Assays	2021

Article

Year

Middle East Fertility Society journal, 2021, Volume: 26, Issue:1

Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Basigin; beta-Transducin Repeat-Containing Proteins; Brain Neoplasms; Butadienes; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diabetic Cardiomyopathies; Diet, High-Fat; Dietary Supplements; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Endoribonucleases; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; Humans; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; NF-E2-Related Factor 2; Nitriles; Phosphorylation; Rats; Signal Transduction; Sumoylation; Temozolomide; Unfolded Protein Response; X-Box Binding Protein 1; Xenograft Model Antitumor Assays

2021

Other Studies

2 other study(ies) available for temozolomide and u 0126

Article	Year
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. Molecular cancer therapeutics, 2010, Volume: 9, Issue:7 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Blotting, Western; Butadienes; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Melanoma; Melphalan; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Nitriles; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rats; Rats, Nude; Sorafenib; Temozolomide; Tumor Burden; Xenograft Model Antitumor Assays	2010
The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle. Cellular signalling, 2011, Volume: 23, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; DNA Damage; DNA Methylation; Drug Synergism; Enzyme Activation; ErbB Receptors; Gefitinib; Humans; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylation; Quinazolines; Signal Transduction; Temozolomide; Triazenes	2011

Article

Year

Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy.

Molecular cancer therapeutics, 2010, Volume: 9, Issue:7

Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Blotting, Western; Butadienes; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Melanoma; Melphalan; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Nitriles; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rats; Rats, Nude; Sorafenib; Temozolomide; Tumor Burden; Xenograft Model Antitumor Assays

2010

The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle.

Cellular signalling, 2011, Volume: 23, Issue:4

Topics: Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; DNA Damage; DNA Methylation; Drug Synergism; Enzyme Activation; ErbB Receptors; Gefitinib; Humans; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylation; Quinazolines; Signal Transduction; Temozolomide; Triazenes

2011